三個皮匠報告
政策庫
new
付費
搜索

危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長-行業數據

危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長
2022 年危重癥領域相關耗材產品在國內市場實現銷售收入 2.29 億元，同比+32.47%，由于危重癥領域 HA330、HA380 血液灌流器產品可以控制新冠重癥患者炎癥因子風暴，改善臟器功能，該系列產品在腎病及肝病領域產品下滑的階段實現了逆勢增長
其它 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?9KB 圖片尺寸：1811*1038
同報告圖片
 / 25
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第1頁
fCDlubTku70gfCDlm73lhoXluILlnLrljbHph43nl4fkuqflk4HplIDllK7mlLblhaXvvIjnmb7kuIflhYPvvIkgfCDlkIzmr5Tlop7pgJ8gfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAyMEEgfCAxMDUuNiAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICB8CnwgMjAyMUEgfCAxNzMuMCAgICAgICAgICAgICAgICAgICAgICAgfCA2My45JSAgICB8CnwgMjAyMkEgfCAyMjkuMCAgICAgICAgICAgICAgICAgICAgICAgfCAzMi41JSAgICB8CgoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45YWs5ZGK77yM5Zu96YeR6K+B5Yi456CU56m25omA
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第2頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第3頁
5qC55o2u5Zu+54mH5Lit55qE5p+x54q25Zu+77yM5Y+v5Lul5o+Q5Y+W5Lul5LiL5pWw5o2u77yaCgp8IOmhueebriAgICAgICAgICAgICAgICAgICAgICAgICB8IOS7t+agvO+8iOWFg++8iSB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IOagh+WHhuiwg+aVtOWJjeihgOa2sueBjOa1gemhueebruacgOmrmOaMh+WvvOS7tyB8IDI4NSAgICAgICAgfAp8IOiwg+aVtOWQjuS4iee6p+WMu+mZouacgOmrmOaMh+WvvOS7tyAgICAgICB8IDM2OSAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya54+g5rW35biC5Yy75L+d5bGA77yM5Zu96YeR6K+B5Yi456CU56m25omA
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第4頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第5頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第6頁
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
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第7頁
5qC55o2u5Zu+54mH5YaF5a6577yM5Lul5LiL5piv5pWw5o2u55qE6KGo5qC85bGV56S677yaCgp8IOS6p+WTgeexu+WIqyB8IOW4guWcuuS7veminSB8CnwgOi0tOiB8IDotLTogfAp8IOWBpeW4hueUn+eJqSB8IDcwJeS7peS4iiB8Cnwg5YW25LuW5Lqn5ZOBIHwg5Ymp5L2Z6YOo5YiGIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOWumOe9kSwg5Zu96YeR6K+B5Yi456CU56m25omA
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第8頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第9頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第10頁
fCDlm77niYcgfCAyMDIz5bm05paw5LiK5biCcEhB57O75YiX5Lqn5ZOB55qE5Zu+54mHIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCDkuqflk4HlkI3np7AgfCBwSEExMzDkuIDmrKHmgKfkvb/nlKjooYDmtrLngYzmtYHlmaggfAp8IOeUn+S6p+aJueWPtyB8IOingeagh+etviB8Cnwg55Sf5Lqn5pel5pyfIHwg6KeB5qCH562+IHwKfCDlpLHmlYjml6XmnJ8gfCDop4HmoIfnrb4gfAp8IOacjeWKoee8lueggSB8IOingeagh+etviB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlrpjnvZHvvIzlm73ph5Hor4HliLjnoJTnqbbmiYA=
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第11頁
fCDlm77ooagxOTog5Y+M6YeN6KGA5rWG5YiG56a75ZC46ZmE57O757uf77yIRFBNQVPvvInmsrvnlpfmqKHlvI8gfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCDmipflh53liYIgfCDooYDmtYbms7UgfCDooYDmtYbliIbnprvlmaggfCDooYDmtYbms7UgfCBCUzMzMCB8IEhBMzMwLUlJIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45a6Y572R77yM5Zu96YeR6K+B5Yi456CU56m25omA
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第12頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第13頁
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
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第14頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第15頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第16頁
fCDlubTku70gfCDlm73lhoXluILlnLrljbHph43nl4fkuqflk4HplIDllK7mlLblhaXvvIjnmb7kuIflhYPvvIkgfCDlkIzmr5Tlop7pgJ8gfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAyMEEgfCAxMDUuNiAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICB8CnwgMjAyMUEgfCAxNzMuMCAgICAgICAgICAgICAgICAgICAgICAgfCA2My45JSAgICB8CnwgMjAyMkEgfCAyMjkuMCAgICAgICAgICAgICAgICAgICAgICAgfCAzMi41JSAgICB8CgoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45YWs5ZGK77yM5Zu96YeR6K+B5Yi456CU56m25omA
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第17頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第18頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第19頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第20頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第21頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第22頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第23頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第24頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第25頁
危重癥相關產品（HA330、HA380、CA系列）收入保持快速增長_第26頁
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
所屬報告： 健帆生物-公司研究報告-經營業績柳暗花明創新推廣拾級而上-240504（21頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站